Overview

• Dr. Aseem Malhotra told The Daily Beast the administration could remove the COVID-19 vaccine from the U.S. market within months, potentially through staged decisions or a single action.
• Malhotra asserted that ACIP is reviewing reported vaccine injuries, though no official regulatory action has been announced.
• The White House responded that any talk of HHS policy not formally announced should be treated as baseless speculation and said it is relying on gold-standard science.
• HHS under Robert F. Kennedy Jr. has already canceled roughly $500 million in mRNA vaccine research funding, signaling a shift in priorities.
• Malhotra cited a 2022 Vaccine journal paper on serious adverse events that many scientists have criticized as methodologically flawed and misleading.